Mdax (Performanceindex (MDAX.MDAX)

Close: 29 120.00 (-564.25), Jun 19, 2025
Weak Positive

Low risk

Automatic technical analysis. Medium term, Jun 19, 2025

Mdax (Performanceindex) shows strong development within a rising trend channel in the medium long term. This signals increasing optimism among investors and indicates continued rise. The index has support at points 27300 and resistance at points 30200. The index is assessed as technically slightly positive for the medium long term.

Recommendation one to six months: Weak Positive (Score: 37)

Period  
Vol.bal. Volatility Liquidity +/- %
1 day-0.83%0.00-1.90%
5 days0.002.68%0.00-3.58%
22 days0.007.21%0.00-4.68%
66 days0.0012.90%0.00+2.28%

More analyses of Mdax (Performanceindex)

chart Mdax (Performanceindex) (MDAX) Candlesticks 22 Days
Candlesticks
chart Mdax (Performanceindex) (MDAX) Short term
Short term: Weak Positive
chart Mdax (Performanceindex) (MDAX) Medium term
Medium term: Weak Positive
chart Mdax (Performanceindex) (MDAX) Long term
Long term: Hold
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.